ResearcherGuiyang Medical UniversityActive in the last 2 years

Chao Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8391-4080; OpenAlex author ID A5053397364. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 11

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers

Papers 3

Sciellin inhibits senescence and promotes pancreatic cancer progress by activating the notch signaling pathway. Last author DOI 10.1038/s41598-025-88265-0 ↗
LNP-enclosed NamiRNA inhibits pancreatic cancer proliferation and migration via dual pathways. Co-author DOI 10.1186/s12951-025-03550-4 ↗
FOXD1 facilitates pancreatic cancer cell proliferation, invasion, and metastasis by regulating GLUT1-mediated aerobic glycolysis. Co-author DOI 10.1038/s41419-022-05213-w ↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shiyu Chen · 2 shared papers, 2022–2025 · strength 0.46
- Paper Sciellin inhibits senescence and promotes pancreatic cancer progress by activating the notch signaling pathway. DOI 10.1038/s41598-025-88265-0 ↗
- Paper FOXD1 facilitates pancreatic cancer cell proliferation, invasion, and metastasis by regulating GLUT1-mediated aerobic g… DOI 10.1038/s41419-022-05213-w ↗
Zhiwei He · 2 shared papers, 2022–2025 · strength 0.46
- Paper Sciellin inhibits senescence and promotes pancreatic cancer progress by activating the notch signaling pathway. DOI 10.1038/s41598-025-88265-0 ↗
- Paper FOXD1 facilitates pancreatic cancer cell proliferation, invasion, and metastasis by regulating GLUT1-mediated aerobic g… DOI 10.1038/s41419-022-05213-w ↗
Chengyi Sun · 1 shared paper, 2025 · strength 0.28
- Paper Sciellin inhibits senescence and promotes pancreatic cancer progress by activating the notch signaling pathway. DOI 10.1038/s41598-025-88265-0 ↗
Jinlong Yu · 1 shared paper, 2025 · strength 0.28
- Paper LNP-enclosed NamiRNA inhibits pancreatic cancer proliferation and migration via dual pathways. DOI 10.1186/s12951-025-03550-4 ↗
Changhao Wu · 1 shared paper, 2025 · strength 0.28
- Paper Sciellin inhibits senescence and promotes pancreatic cancer progress by activating the notch signaling pathway. DOI 10.1038/s41598-025-88265-0 ↗
Zhuo Wu · 1 shared paper, 2025 · strength 0.28
- Paper LNP-enclosed NamiRNA inhibits pancreatic cancer proliferation and migration via dual pathways. DOI 10.1186/s12951-025-03550-4 ↗
Zhou Fang · 1 shared paper, 2025 · strength 0.28
- Paper LNP-enclosed NamiRNA inhibits pancreatic cancer proliferation and migration via dual pathways. DOI 10.1186/s12951-025-03550-4 ↗
Rufu Chen · 1 shared paper, 2025 · strength 0.28
- Paper LNP-enclosed NamiRNA inhibits pancreatic cancer proliferation and migration via dual pathways. DOI 10.1186/s12951-025-03550-4 ↗
Kun Cai · 1 shared paper, 2022 · strength 0.17
- Paper FOXD1 facilitates pancreatic cancer cell proliferation, invasion, and metastasis by regulating GLUT1-mediated aerobic g… DOI 10.1038/s41419-022-05213-w ↗
Lin Li · 1 shared paper, 2022 · strength 0.17
- Paper FOXD1 facilitates pancreatic cancer cell proliferation, invasion, and metastasis by regulating GLUT1-mediated aerobic g… DOI 10.1038/s41419-022-05213-w ↗
Cheng-Yi Sun · 1 shared paper, 2022 · strength 0.17
- Paper FOXD1 facilitates pancreatic cancer cell proliferation, invasion, and metastasis by regulating GLUT1-mediated aerobic g… DOI 10.1038/s41419-022-05213-w ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.